MedTrace Logo

Nitric Oxide Lung Diffusing Capacity in Healthy, Non-smoking Adults

NCT04016597 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2020-02-11

No results posted yet for this study

Summary

The measurement of nitric oxide lung diffusing capacity (DLNO) has been recently standardised. To date, two pulmonary function devices are commercially available and are used for the measurement of DLNO. No previous study assessed differences in gas exchange outcomes (e.g., DLNO values) between both devices.

The aim of this project is to compare two commercially available devices that measure lung diffusing capacity for nitric oxide (DLNO).

1. "MasterScreenTM" (PFT Pro, Jaeger, CareFusion, Hoechberg, Germany
2. "HypAir" ("HA", Medisoft, Dinant, Belgium).

Conditions

  • Healthy

Interventions

DEVICE

Jaeger Masterscreen TM

Single-breath nitric oxide lung diffusing capacity

DEVICE

HypAir Medisoft

Single-breath nitric oxide lung diffusing capacity

Sponsors & Collaborators

  • University of Zurich

    lead OTHER

Principal Investigators

  • Thomas Radtke, PhD · University of Zurich, EBPI, Switzerland

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-01
Primary Completion
2020-01-31
Completion
2020-01-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04016597 on ClinicalTrials.gov